These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 10636753

  • 1. Spironolactone in patients with heart failure.
    Vanpee D, Swine C.
    N Engl J Med; 2000 Jan 13; 342(2):133; author reply 133-4. PubMed ID: 10636753
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.
    Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA.
    N Engl J Med; 2004 Aug 05; 351(6):543-51. PubMed ID: 15295047
    [Abstract] [Full Text] [Related]

  • 5. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M, Takada M, Hirooka K, Isobe F, Yasumura Y.
    J Clin Pharm Ther; 2005 Dec 05; 30(6):603-10. PubMed ID: 16336294
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Drug safety in patients with heart failure.
    Juurlink DN, Hansten PD.
    Arch Intern Med; 2005 Jan 10; 165(1):118. PubMed ID: 15642888
    [No Abstract] [Full Text] [Related]

  • 9. [Late drug-induced hyperkalemia in a patient with congestive heart failure].
    Konopa J, Bułło B, Rutkowski B.
    Przegl Lek; 2005 Jan 10; 62(7):732-3. PubMed ID: 16463712
    [Abstract] [Full Text] [Related]

  • 10. Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone.
    Erden I, Yalcin S, Ozhan H.
    Kardiol Pol; 2010 Sep 10; 68(9):1043-5; discussion 1046. PubMed ID: 20859899
    [Abstract] [Full Text] [Related]

  • 11. [Drug-related hyperkalemia resulted from spironolactone and angiotensin converting enzyme inhibitors therapy].
    Dutka M, Dzielski T, Wojciechowska J, Heller L, Trybus M.
    Pol Merkur Lekarski; 1999 Aug 10; 7(38):69-70. PubMed ID: 10522422
    [Abstract] [Full Text] [Related]

  • 12. Study warns of danger of combining spironolactone and ACE inhibitors in heart patients.
    Gottlieb S.
    BMJ; 2004 Aug 21; 329(7463):420. PubMed ID: 15321896
    [No Abstract] [Full Text] [Related]

  • 13. Elderly heart failure patients with drug-induced serious hyperkalemia.
    Vanpee D, Swine CH.
    Aging (Milano); 2000 Aug 21; 12(4):315-9. PubMed ID: 11073352
    [Abstract] [Full Text] [Related]

  • 14. Risk of hyperkalemia and combined use of spironolactone and long-term ACE inhibitor/angiotensin receptor blocker therapy in heart failure using real-life data: a population- and insurance-based cohort.
    Abbas S, Ihle P, Harder S, Schubert I.
    Pharmacoepidemiol Drug Saf; 2015 Apr 21; 24(4):406-13. PubMed ID: 25683504
    [Abstract] [Full Text] [Related]

  • 15. [Effects of the RALE study. Hyperkalemia following spironolactone treatment].
    Erdmann E.
    Internist (Berl); 2005 Apr 21; 46(4):466, 468. PubMed ID: 15723149
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of aldosterone antagonism in heart failure: pharmacotherapeutic options].
    Diercks GF, Overdiek JW, van Veldhuisen DJ.
    Ned Tijdschr Geneeskd; 2001 Feb 03; 145(5):204-8. PubMed ID: 11219145
    [Abstract] [Full Text] [Related]

  • 17. New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.
    Cruz CS, Cruz LS, Domingues GS, Souza CA.
    Expert Opin Drug Saf; 2005 Jul 03; 4(4):677-88. PubMed ID: 16011447
    [Abstract] [Full Text] [Related]

  • 18. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J, Fraccarollo D.
    Minerva Cardioangiol; 2003 Apr 03; 51(2):155-64. PubMed ID: 12783071
    [Abstract] [Full Text] [Related]

  • 19. Hyperkalaemia in the age of aldosterone antagonism.
    Chapagain A, Ashman N.
    QJM; 2012 Nov 03; 105(11):1049-57. PubMed ID: 22723454
    [Abstract] [Full Text] [Related]

  • 20. [In the age of ACE inhibitors are there still indications for spironolactone in heart failure?].
    Böhm M.
    Internist (Berl); 1995 Feb 03; 36(2):179-80. PubMed ID: 7737809
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.